NIH-funded research R01 grant

Using collagen-derived peptides to reduce inflammation after heart attacks

Official title: Collagen-derived peptides to target inflammation in myocardial infarction

Funded at East Carolina University · NIH-10980527 · Data updated 2026-11-12

This study is looking at a special protein that might help reduce harmful inflammation after a heart attack, making it easier for your heart to heal while still doing its important repair work.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEast Carolina University
NIH-funded
Lab location1 site (Greenville, United States)
Project startDecember 15, 2021
Project endNovember 30, 2025
Funding year2025
Award (this year)$373,834
NIH project number5R01HL152297-04
Project IDNIH-10980527 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have recently experienced a myocardial infarction and are at risk of developing heart failure.

Less likely to help

Patients who have not had a heart attack or those with advanced heart failure may not benefit from this research.

What this research studies

This research investigates the use of a specific peptide derived from collagen to target inflammation following a myocardial infarction (heart attack). The approach focuses on modulating the activity of matrix metalloproteinase-9 (MMP-9), which plays a crucial role in the healing process but can also contribute to adverse heart remodeling. By using the peptide p1159, the research aims to reduce harmful inflammation while allowing MMP-9 to perform its necessary functions in tissue repair. This could lead to improved outcomes for patients recovering from heart attacks.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance recovery and reduce the risk of heart failure after a heart attack.

How similar studies have gone: Previous research has shown promise in targeting MMP-9 for cardiac conditions, but this specific approach using collagen-derived peptides is novel.

Where this research is happening

  • East Carolina University
    Greenville, United States
    Active

Researchers

  • Principal investigator: De Castro Braz, Lisandra E — East Carolina University
  • Study coordinator: De Castro Braz, Lisandra E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.